LITTLE KNOWN FACTS ABOUT CONOLIDINE.

These results, together with a previous report demonstrating that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two support the concept of focusing on ACKR3 as a singular approach to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar disorders.So, before investing in this sup